Algo version: 0.98b
Heidelberg Pharma AG is listed at the XETRA Exchange
Heidelberg Pharma AG [HPHA.DE]
XETRA Sector: Biotechnology Industry:Biotechnology

Is Heidelberg Pharma AG stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

We cannot find any recorded dividends paid in our systems.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Heidelberg Pharma AG 10 years ago, but if you had invested on Monday 9th of September 2019 when the price was €2.25, you would have made a profit of €0.260 per share or 11.56%

No, the average daily trading liquidity for Heidelberg Pharma AG is €3 754 thousand. Trading in stocks with this little trading liquidity is very dangerous, and you can get into a situation where it will be hard to trade your stocks. In addition, these types of stocks usually have very high volatility.

Heidelberg Pharma AG has little of the business financed by loans. This puts the company at lower risk in periods of high inflation where borrowing costs usually go up. The company is still not profitable, and high inflation will make it harder to become profitable as costs increase and consumer spending decreases.

We have calculated the inflation risk for Heidelberg Pharma AG to be medium [0.7 of 1]

US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.